Table 2.
Characteristic | Total n=80 |
---|---|
Age (years) | 50 ± 18 |
Female sex | 43 (54) |
Self-reported race/ethnicity | |
African American | 45 (56) |
European | 13 (16.5) |
Hispanic | 13 (16.5) |
Other | 9 (11) |
Warfarin indication | |
Deep vein thrombosis | 25 (31) |
Pulmonary embolism | 20 (25) |
Atrial fibrillation | 12 (15) |
VTE prophylaxis after major orthopedic surgery | 11 (14) |
Other | 12 (15) |
Genotype | |
VKORC1 -1639G>A | |
AA | 8 (10) |
AG | 21 (26) |
GG | 51 (64) |
CYP2C9 | |
*1/*1 | 68 (85) |
*1/*2 | 10 (13) |
*1/*3 | 1 (1) |
*2/*2 | 1 (1) |
CYP4F2 V433M | |
VV | 56 (70) |
VM | 21 (26) |
MM | 3 (4) |